Deeper understandings of the implications of altered expressions of MEIS1, AGTR1, BAK1, DTL and TYMS, call for detailed clinical studies for further insights into HNSCC pathogenesis. The gene discussed is BAK1; the disease is head and neck squamous cell carcinoma.